Skip to main content
Tech.euFundingExplorerBeta

Vectivbio

VectivBio is a clinical-stage biotechnology company.

Vectivbio has raised €303M across 4 funding rounds from 13 investors, most recently a round in Oct 2022. Based in Basel, Switzerland; founded 2019; active in Healthtech. Data as of 28 Oct 2026.

Basel, SwitzerlandFounded 2019vectivbio.com ↗
Total raised
€303M
€302,888,161
Funding rounds
4
Investors
13
distinct backers
Active since
2020-09
latest 2022-10

Funding by year

EUR raised per year
Vectivbio — funding by year — interactive chart.
Data table
Vectivbio — funding by year
2020€123M
2022€180M

Signals

High confidence
Raise-next likelihood6
base rate 30% for Other
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood15
base rate 11% (2+ rounds)
  • ▲ €100M+ raised
  • ▲ 4 rounds raised
  • ▲ 7y since founding (typical exit age)
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
2022-10-20Other€127MCowen Healthcare Investments,Driehaus Capital Management,Eventide Asset Management,Forbion's Growth Opportunities Fund,Frazier Life Sciences,Marshall Wace+5 moreView deal →
2022-07-05Other€52MForbion,Private investorView deal →
2020-10-19Other€94M—View deal →
2020-09-01Series A€29M—View deal →

Similar companies

same sector or country

Global coverage: FundingData